Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Bioorg Med Chem Lett ; 22(8): 2877-9, 2012 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-22425452

RESUMO

We report the synthesis and biological evaluation of a series of novel α-branched pyrazinoyl quaternary amines for their ability to block ion transport via the epithelial sodium channel (ENaC) in human bronchial epithelial cells (HBECs). Compound 12 g has an IC(50) of 30 nM and is highly efficacious in the Guinea-pig tracheal potential difference (TPD) model of ENaC blockade with an ED(50) of 1 µg kg(-1) at 1h. In addition the SAR results demonstrate for the first time the chiral nature of the binding site of human ENaC. As such, pyrazinoyl quaternary amines represent a promising new class of ENaC blockers for the treatment of cystic fibrosis that are structurally distinct from the pyrazinoyl guanidine chemotype found in prototypical ENaC blockers such as amiloride.


Assuntos
Aminas/química , Bloqueadores do Canal de Sódio Epitelial , Pirazinas/química , Bloqueadores dos Canais de Sódio/química , Aminas/farmacologia , Animais , Sítios de Ligação , Brônquios/efeitos dos fármacos , Células Epiteliais/efeitos dos fármacos , Cobaias , Humanos , Concentração Inibidora 50 , Modelos Moleculares , Estrutura Molecular , Pirazinas/farmacologia , Bloqueadores dos Canais de Sódio/farmacologia
2.
Bioorg Med Chem Lett ; 22(2): 929-32, 2012 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-22197144

RESUMO

We report the identification of a novel series of human epithelial sodium channel (ENaC) blockers that are structurally distinct from the pyrazinoyl guanidine chemotype found in prototypical ENaC blockers such as amiloride. Following a rational design hypothesis a series of quaternary amines were prepared and evaluated for their ability to block ion transport via ENaC in human bronchial epithelial cells (HBECs). Compound 11 has an IC(50) of 200nM and is efficacious in the Guinea-pig tracheal potential difference (TPD) model of ENaC blockade with an ED(50) of 44µgkg(-1) at 1h. As such, pyrazinoyl quaternary amines represent the first examples of a promising new class of human ENaC blockers.


Assuntos
Aminas/química , Desenho de Fármacos , Células Epiteliais/efeitos dos fármacos , Bloqueadores do Canal de Sódio Epitelial , Bloqueadores dos Canais de Sódio/síntese química , Bloqueadores dos Canais de Sódio/farmacologia , Aminas/farmacologia , Brônquios/citologia , Relação Dose-Resposta a Droga , Células Epiteliais/metabolismo , Canais Epiteliais de Sódio/metabolismo , Humanos , Bloqueadores dos Canais de Sódio/química , Relação Estrutura-Atividade
3.
Pharmacol Ther ; 142(2): 196-205, 2014 May.
Artigo em Inglês | MEDLINE | ID: mdl-24333263

RESUMO

Pneumonectomy (PNX) in experimental animals leads to a species- and age-dependent compensatory growth of the remaining lung lobes. PNX mimics the loss of functional gas exchange units observed in a number of chronic destructive lung diseases. However, unlike in disease models, this tissue loss is well defined, reproducible and lacks accompanying inflammation. Furthermore, compensatory responses to the tissue loss can be easily quantified. This makes PNX a potentially useful model for the study of the cellular and molecular events which occur during realveolarisation. It may therefore help to get a better understanding of how to manipulate these pathways, in order to promote the generation of new alveolar tissue as therapies for destructive lung diseases. This review will explore the insights that experimental PNX has provided into the physiological factors which promote compensatory lung growth as well as the importance of age and species in the rate and extent of compensation. In addition, more recent studies which are beginning to uncover the key cellular and molecular pathways involved in realveolarisation will be discussed. The potential relevance of experimental pneumonectomy to novel therapeutic strategies which aim to promote lung regeneration will also be highlighted.


Assuntos
Pulmão/crescimento & desenvolvimento , Pulmão/cirurgia , Pneumonectomia , Regeneração , Fatores Etários , Animais , Humanos , Peptídeos e Proteínas de Sinalização Intercelular/metabolismo , Pulmão/metabolismo , Pneumopatias/metabolismo , Pneumopatias/fisiopatologia , Modelos Animais , Transdução de Sinais , Especificidade da Espécie
4.
Expert Rev Clin Pharmacol ; 3(3): 361-9, 2010 May.
Artigo em Inglês | MEDLINE | ID: mdl-22111616

RESUMO

Ion channels control the hydration status of the airway epithelium through apical anion secretion and cation absorption, which is accompanied by osmotically obligated water. The key channels in this process are the cystic fibrosis (CF) transmembrane conductance regulator (CFTR), which is principally responsible for Cl(-) secretion by airway epithelial cells, and the epithelial Na(+) channel (ENaC), which is responsible for the absorption of Na ions. In CF, defective CFTR-mediated Cl(-) secretion and an accompanying upregulation in ENaC-mediated Na absorption results in a reduction in airway surface liquid volume, leading to poorly hydrated mucus and impaired mucociliary clearance. Restoration of normal airway hydration by modulation of ion channel activity represents an important therapeutic strategy for CF. CFTR corrector and potentiator compounds are being developed with the aim of recovering normal Cl(-) secretion. Ca(2+)-activated Cl(-) channels (CaCCs) are expressed by the respiratory epithelia and are reported to be functionally upregulated in CF and offer a 'surrogate' pathway for Cl(-) secretion. TMEM16A has recently been described as a CaCC in the airway epithelium and, as such, represents an alternative target for restoring Cl(-) secretion in CF. An alternative therapeutic strategy for CF is to inhibit ENaC, thereby blocking excessive Na absorption. This can be achieved by direct blockade of ENaC or inhibition of the channel-activating proteases (CAPs), whose activity regulates ENaC function. This review will describe the regulation of airway mucosal hydration by ion channels and the efforts currently underway to restore normal mucosal hydration in disease patients by modulating the function of these channels.

5.
Hum Mol Genet ; 15(2): 259-71, 2006 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-16330480

RESUMO

The transcription factor SOX10 is mutated in the human neurocristopathy Waardenburg-Shah syndrome (WS4), which is characterized by enteric aganglionosis and pigmentation defects. SOX10 directly regulates genes expressed in neural crest lineages, including the enteric ganglia and melanocytes. Although some SOX10 target genes have been reported, the mechanisms by which SOX10 expression is regulated remain elusive. Here, we describe a transgene-insertion mutant mouse line (Hry) that displays partial enteric aganglionosis, a loss of melanocytes, and decreased Sox10 expression in homozygous embryos. Mutation analysis of Sox10 coding sequences was negative, suggesting that non-coding regulatory sequences are disrupted. To isolate the Hry molecular defect, Sox10 genomic sequences were collected from multiple species, comparative sequence analysis was performed and software was designed (ExactPlus) to identify identical sequences shared among species. Mutation analysis of conserved sequences revealed a 15.9 kb deletion located 47.3 kb upstream of Sox10 in Hry mice. ExactPlus revealed three clusters of highly conserved sequences within the deletion, one of which shows strong enhancer potential in cultured melanocytes. These studies: (i) present a novel hypomorphic Sox10 mutation that results in a WS4-like phenotype in mice; (ii) demonstrate that a 15.9 kb deletion underlies the observed phenotype and likely removes sequences essential for Sox10 expression; (iii) combine a novel in silico method for comparative sequence analysis with in vitro functional assays to identify candidate regulatory sequences deleted in this strain. These studies will direct further analyses of Sox10 regulation and provide candidate sequences for mutation detection in WS4 patients lacking a SOX10-coding mutation.


Assuntos
Sequência de Bases/genética , Embrião de Mamíferos/metabolismo , Regulação da Expressão Gênica no Desenvolvimento , Proteínas de Grupo de Alta Mobilidade/metabolismo , Deleção de Sequência/genética , Fatores de Transcrição/metabolismo , Síndrome de Waardenburg/genética , Algoritmos , Animais , Southern Blotting , Células Cultivadas , Sequência Conservada/genética , Análise Mutacional de DNA , Componentes do Gene , Proteínas de Grupo de Alta Mobilidade/genética , Hibridização In Situ , Luciferases , Camundongos , Camundongos Transgênicos , Dados de Sequência Molecular , Fatores de Transcrição SOXE , Análise de Sequência de DNA , Especificidade da Espécie , Fatores de Transcrição/genética , Transgenes/genética
6.
Med Mycol ; 43(5): 397-401, 2005 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-16178367

RESUMO

We describe a kinetic microbroth method of measuring the growth rate of Aspergillus fumigatus spectrophotometrically. Using this method, growth rates were determined for nine A. fumigatus isolates for which an LD90 value in immunosuppressed CD-1 mice had previously been obtained. Comparison of the growth rates and LD90 values of these isolates suggests that a correlation exists between the two parameters.


Assuntos
Aspergilose/microbiologia , Aspergillus fumigatus/crescimento & desenvolvimento , Aspergillus fumigatus/patogenicidade , Processos de Crescimento Celular/fisiologia , Virulência , Animais , Aspergilose/tratamento farmacológico , Aspergilose/mortalidade , Aspergillus fumigatus/classificação , Aspergillus fumigatus/metabolismo , Camundongos
7.
Am J Pathol ; 164(6): 2279-88, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15161660

RESUMO

The prion protein (PrP) and Doppel (Dpl) have many structural and biochemical properties in common, leading to the suggestion that the lack of an obvious phenotype in PrP-deficient mice maybe because of compensation by Dpl. To test this hypothesis and also investigate the function of Dpl we have generated Prnd(-/-) and Prnp(-/-)/Prnd(-/-) mouse lines. Both develop normally and display an identical male sterility phenotype that differs from that reported for another Prnd(-/-) mouse line. Sperm from both our mutant lines were present at normal concentrations, had normal motility, and no morphological abnormalities. Despite only rarely fertilizing oocytes in vivo, because of an inability to perform the acrosome reaction, mutant sperm were capable of fertilization in vitro, albeit at reduced rates compared to wild type. Elevated levels of oxidative DNA damage were found in both types of mutant sperm and resulting embryos failed at an early stage. Therefore we found no evidence that Dpl compensates for the loss of PrP function in mutant mouse lines, but it does have an important anti-oxidant function necessary for sperm integrity and male fertility.


Assuntos
Dano ao DNA/genética , Fertilização in vitro , Infertilidade Masculina/genética , Príons/genética , Reação Acrossômica , Animais , Sequência de Bases , Cromatina/patologia , Cromatina/ultraestrutura , Primers do DNA , Epididimo , Proteínas Ligadas por GPI , Masculino , Camundongos , Camundongos Knockout , Reação em Cadeia da Polimerase , Príons/fisiologia , Motilidade dos Espermatozoides , Espermatozoides/citologia , Espermatozoides/patologia , Espermatozoides/fisiologia
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa